An observational study in Lyme Borreliosis, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-15.
Sponsored by University Hospital, Strasbourg, France · Observational
Among 13 studies in Lyme Disease with a site in France — 5 open to participants now, 5 under way, none of them phase 3. Lyme Disease · France.
Among the 13 studies in Lyme Disease with a site in France, this one is the only one that started in 2024, is one of 9 observational ones, and was the 9th registered.
97 studies on the registry are indexed under Lyme Disease; 26 are open to participants now.
This study's planned enrollment of 20 is below the median of 400 across 42 observational studies indexed under Lyme Disease.
Browse Lyme Disease studies →5 of the 13 studies in Lyme Disease with a site in France are open now, in 1 country. Each count lists the studies.
Of the 18 Lyme Disease studies recruiting now, 11 (61%) set no upper age limit and 3 (17%) stop at 75 or younger; 7 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →13 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2024.
Median enrollment 56 across the 4 interventional studies, 100 across the 9 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
1 of 13 have an industry lead sponsor. The 7 most frequent:
University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.
University Hospital, Strasbourg, France has 7 studies filed under Lyme Disease — fewer than ten, so there is no comparison to draw.
1 of the studies in Lyme Disease with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05641116Centre Hospitalier Universitaire de Saint EtienneEffectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. | 2026-12 |
Among the 13 studies in Lyme Disease with a site in France, from their registry updates:
Ticks are blood-sucking arthropods that feed on vertebrate hosts. Although wild and domestic animals are the primary source of tick blood meals, humans can be an accidental host. During a blood meal, a microorganism can be transmitted to the host who can develop a disease. All infectious diseases transmitted by ticks are referred to as tick-borne diseases (TBDs). They are the most prevalent vector-borne diseases in the Northern Hemisphere. Among these diseases, Lyme borreliosis is the most common.
In Europe, Lyme borreliosis does not cause high fevers (> 38°C). Therefore, when a patient presents with a high fever with the notion of exposure to ticks, another etiology must be suspected. Anaplasma phagocytophilum and the tick-borne encephalitis virus are classically described as causing febrile syndromes.
In France, ticks and tick-borne diseases are increasing, particularly those associated with the Ixodes ricinus tick. This tick is mainly present in forest ecosystems with a peak of activity in May. Foresters represent a population with biting ticks and tick-borne diseases, notably Lyme borreliosis.
Major forester (≥18 years old), ONF (National Forestry Office) staff regularly exposed to ticks in Alsace.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Number of ticks found on clothing during activities in forest ecosystems, and if tick bites, their number.
This study is carried out on foresters in the Alsacce region over a period of one year.
Time frame: 1 year
Started Jan 2024 (actual). Primary completion is estimated for Jul 2025, 18 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →